Tender For Coronary Drug Eluting Stents With (1) Stent On Cobalt Chromium Alloy Or Platinum Chromium Alloy. (2) Stent With Coating Of Polymer Carrier For Active Drug ( Sirolimus, Everolimus Or Zotarolimus Shown To Be Effective In Preventing Neo-Intim, perambalur-Tamil Nadu

Supply Of Coronary Drug Eluting Stents With ( 1 ) Stent On Cobalt Chromium Alloy Or Platinum Chromium Alloy. ( 2 ) Stent With Coating Of Polymer Carrier For Active Drug ( Sirolimus, Everolimus Or Zotarolimus Shown To Be Effective In Preventing Neo-Intimal Hyperplasia ) ( 3 ) Stent Diameter Should Be From 2.5Mm To 4Mm . The Length Of The Stent Should Be 12 To 48Mm . ( 4 ) The Strut Thickness Should Be 91 Micron Or Less. ( 5 ) Stent Delivery System Should Be Monorail ( Single Operator Exchange Or Rapid Exchange ) . ( 6 ) Stent Should Be Compatible With 5Fr Guiding Catheter ( 7 ) Stent Design Should Be Open Cell Type. ( 8 ) Stent Should Be Approved By Dcgi. The Copy Of Dcgi Approval Should Be Enclosed In The Tender Bid / Offer. ( 9 ) The Long Term Efficacy And Safety Of The Stent, The Rates Of In-Stent Restenosis ( Isr ) And In-Situ Thrombosis ( Ist ) Should Be Documented / Published In Peer Reviewed Scientific Journals. ( 10 ) The Manufacturer / Supplier Should Submit Proof Of Supply Of The Stent To A Major Government Institute.Bis Standards For The Drug Eluting Stent Are Not Available ( Reference : Bis Catalogue ) Unit:Nocoronary Drug Eluting Stents With ( 1 ) Stent On Cobalt Chromium Alloy Or Platinum Chromium Alloy. ( 2 ) Stent With Coating Of Polymer Carrier For Active Drug ( Sirolimus, Everolimus Or Zotarolimus Shown To Be Effective In Preventing Neo-Intimal Hyperplasia ) ( 3 ) Stent Diameter Should Be From 2.5Mm To 4Mm . The Length Of The Stent Should Be 12 To 48Mm . ( 4 ) The Strut Thickness Should Be 91 Micron Or Less. ( 5 ) Stent Delivery System Should Be Monorail ( Single Operator Exchange Or Rapid Exchange ) . ( 6 ) Stent Should Be Compatible With 5Fr Guiding Catheter ( 7 ) Stent Design Should Be Open Cell Type. ( 8 ) Stent Should Be Approved By Dcgi. The Copy Of Dcgi Approval Should Be Enclosed In The Tender Bid / Offer. ( 9 ) The Long Term Efficacy And Safety Of The Stent, The Rates Of In-Stent Restenosis ( Isr ) And In-Situ Thrombosis ( Ist ) Should Be Documented / Published In Peer Reviewed Scientific Journals. ( 10 ) The Manufacturer / Supplier Should Submit Proof Of Supply Of The Stent To A Major Government Institute.Bis Standards For The Drug Eluting Stent Are Not Available ( Reference : Bis Catalogue ) Unit:No, Coronary Drug Eluting Stents With ( 1 ) Stent On Cobalt Chromium Alloy Or Platinum Chromium Alloy. ( 2 ) Stent With Coating Of Polymer Carrier For Active Drug ( Sirolimus, Everolimus Or Zotarolimus Shown To Be Effective In Preventing Neo-Intimal Hyperplasia ) ( 3 ) Stent Diameter Should Be From 2.5Mm To 4Mm . The Length Of The Stent Should Be 12 To 48Mm . ( 4 ) The Strut Thickness Should Be 91 Micron Or Less. ( 5 ) Stent Delivery System Should Be Monorail ( Single Operator Exchange Or Rapid Exchange ) . ( 6 ) Stent Should Be Compatible With 5Fr Guiding Catheter ( 7 ) Stent Design Should Be Open Cell Type. ( 8 ) Stent Should Be Approved By Dcgi. The Copy Of Dcgi Approval Should Be Enclosed In The Tender Bid / Offer. ( 9 ) The Long Term Efficacy And Safety Of The Stent, The Rates Of In-Stent Restenosis ( Isr ) And In-Situ Thrombosis ( Ist ) Should Be Documented / Published In Peer Reviewed Scientific Journals. ( 10 ) The Manufacturer / Supplier Should Submit Proof Of Supply Of The Stent To A Major Government Institute.Bis Standards For The Drug Eluting Stent Are Not Available ( Reference : Bis Catalogue ) Unit:No

Refer document

Refer document

Refer document